Decompensated liver cirrhosis

Curative effect of combined lamivudine, adefovir dipivoxil, and stem cell transplantation on decompensated hepatitis B cirrhosis

L. Liu, Yan, Y., Zhou, J., Huang, L. W., He, C. P., Ling, K., Zhou, H. C., Wen, Q. M., and Wang, X. M., Curative effect of combined lamivudine, adefovir dipivoxil, and stem cell transplantation on decompensated hepatitis B cirrhosis, vol. 13, pp. 9336-9342, 2014.

This study assessed the clinical efficacy of lamivudine and adefovir dipivoxil combined with autologous bone marrow stem cell transplantation as treatment for patients with hepatitis B and decompensated liver cirrhosis. In total, 77 patients with hepatitis B and decompensated liver cirrhosis were randomly divided into two groups.

Subscribe to Decompensated liver cirrhosis